PRFX
PRF Technologies Ltd.
Set alert
0.73 USD -0.02 -2.68%
0.71 Day range 0.7421
0.712 52-week range 6.20
- YTD
- -77.26%
- 1 year
- -87.83%
- Open
- 0.7271
- Prev close
- 0.7502
- Mkt cap
- 2.55M
- Vol
- 58.59K
- Avg vol
- 260.32K
- EPS
- -4.09
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.71
- High
- 0.7421
- Forward P/E
- -0.37
- Beta
- 0.56
- Short ratio
- 0.02
- Inst. own
- 6.57%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 29, 2024
- 50-d avg
- 1.84
- 200-d avg
- 3.57
- 1y target
- 0.00
Key statistics
- Market cap
- 3.90M
- Enterprise value
- 339.62K
- Trailing P/E
- 0.00
- Forward P/E
- -0.37
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -147.36
- Beta
- 0.56
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -4.93M
- Total cash
- 2.78M
- Total debt
- 59.00K
- Return on equity
- -716.67%
- Shares outstanding
- 874.86K
- Short % of float
- 9.08%
- 50-day average
- 1.84
- 200-day average
- 3.57
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 29, 2024
Expected Feb 29, 2024. Consensus EPS estimate 0.00.
Financials — quick view
PRFX Revenue — quarterly 0
PRFX Net income — quarterly -7.31M
PRFX EPS — quarterly 10.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 15, 2024 | Jun 1, 2024 | 0.00 | -9.60 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -65.27 | — | — |
| Feb 29, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 15, 2023 | Sep 1, 2023 | 0.00 | 11.52 | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | -52.79 | — | — |
| Mar 16, 2023 | Dec 1, 2022 | 0.00 | -69.59 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 24, 2024 | Maxim Group | down | Buy | Hold |
| Jun 26, 2024 | Maxim Group | reit | Buy | Buy |
About PRF Technologies Ltd.
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Israel
- Website
- painreform.com
News
- 12 Health Care Stocks Moving In Friday's After-Market Session
- PRF Technologies Reports Cash Of ~$11M As Of Sept. 30; Plans To Initiate Enrollment In Its U.S. Multi-Center Clinical Study Of OcuRing-K; Intendws To Estabish GridFeed vAs Standalone Subsidiary
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- PRF Technologies Intends To Establish GridFeed Subsidiary
- 12 Health Care Stocks Moving In Friday's Intraday Session
- PRF Technologies Issues Shareholder Letter Regarding Stronger Financial Position, Diversified Portfolio Of Innovative Technology Businesses, Real Commercial Momentum And Increased Strategic Flexibility
- PRF Technologies Expands Its DeepSolar Predict AI Renewable Energy Sales Optimization Platform With Battery-To-Revenue Intelligence Functionality
- PRF Technologies Unit DeepSolar Completes Initial Validation Phase For Its Predict AI Revenue Optimization Platform
- PRF Technologies Announces PRF-110 And ZYNRELEF Show Reductions In Mechanical Sensitivity Its Previously Reported Preclinical Trial; PRF-110 Demonstrated Slower Absorption Rate Relative To ZYNRELEF; PRF-110 Raise Retention In Local Tissue
Your note
Sign in to keep a note on PRFX — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 0.74% | 6,496 | 28.97K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.49% | 4,308 | 19.21K | Sep 29, 2024 |
| HRT Financial LP | 0.41% | 3,577 | 15.95K | Sep 29, 2024 |
| Osaic Holdings Inc | 0.02% | 192 | 856 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.01% | 80 | 356 | Sep 29, 2024 |